Skip to main content
OpenTrials

Clinical trial condition

Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7

Explore clinical trials studying Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7 trial results

Completed

Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma

NCT03063632

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +33 more
Locations
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma

NCT00961220

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
Locations
  • Henry Ford Hospital Detroit, Michigan, United States
  • Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Case Western Reserve University Cleveland, Ohio, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details

Related conditions